Erratum Regarding “A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT)” (American Journal of Kidney Diseases (2018) 72(1) (30–41), (S0272638618301021), (10.1053/j.ajkd.2017.12.012));A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT)

American Journal of Kidney Diseases

Volumn 72, Issue 1, 2018, Pages 30-41

  Foster, Bethany J ^a,b   Pai, Ahna L H ^c,d   Zelikovsky, Nataliya ^e   Amaral, Sandra ^e,f   Bell, Lorraine ^a,b   Dharnidharka, Vikas R ^g   Hebert, Diane ^h   Holly, Crystal ⁱ   Knauper, Baerbel ^b   Matsell, Douglas ^j   Phan, Veronique ^k   Rogers, Rachel ^e   Smith, Jodi M ^l   Zhao, Huaqing ^m   Furth, Susan L ^e,f  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g ST LOUIS CHILDREN S HOSPITAL   (United States)

^h HOSPITAL FOR SICK CHILDREN   (Canada)

ⁱ UNIVERSITY OF OTTAWA   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k UNIVERSITY OF MONTREAL   (Canada)

^l SEATTLE CHILDREN S HOSPITAL   (United States)

^m TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adherence; adolescent; behavioural; compliance; end stage renal disease (ESRD); graft survival; immunosuppressant; intervention; kidney transplant; kidney transplantation; randomized trial; teen; young adult

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; E-MAIL; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; PARALLEL DESIGN; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REMINDER SYSTEM; TEXT MESSAGING; UNITED STATES; ADOLESCENT BEHAVIOR; CLINICAL TRIAL; GRAFT REJECTION; PSYCHOLOGY; SELF REPORT; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADOLESCENT BEHAVIOR; CHILD; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MEDICATION ADHERENCE; SELF REPORT; TACROLIMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85046024017     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2019.01.009     Document Type: Erratum

References (51)

1. Foster, B.J., Dahhou, M., Zhang, X., Platt, R.W., Samuel, S.M., Hanley, J.A., Association between age and graft failure rates in young kidney transplant recipients. Transplantation 92:11 (2011), 1237–1243.
2. Dobbels, F., Ruppar, T., De Geest, S., Decorte, A., Van Damme-Lombaerts, R., Fine, R.N., Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 14:5 (2010), 603–613.
3. Dew, M.A., Dabbs, A.D., Myaskovsky, L., et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 88:5 (2009), 736–746.
4. Pinsky, B.W., Takemoto, S.K., Lentine, K.L., Burroughs, T.E., Schnitzler, M.A., Salvalaggio, P.R., Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 9:11 (2009), 2597–2606.
5. Sellares, J., de Freitas, D.G., Mengel, M., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12:2 (2011), 388–399.
6. Griva, K., Davenport, A., Harrison, M., Newman, S.P., Non-adherence to immunosuppressive medications in kidney transplantation: intent vs. forgetfulness and clinical markers of medication intake. Ann Behav Med 44:1 (2012), 85–93.
7. Simons, L.E., McCormick, M.L., Mee, L.L., Blount, R.L., Parent and patient perspectives on barriers to medication adherence in adolescent transplant recipients. Pediatr Transplant 13:3 (2009), 338–347.
8. Zelikovsky, N., Schast, A.P., Palmer, J., Meyers, K.E., Perceived barriers to adherence among adolescent renal transplant candidates. Pediatr Transplant 12:3 (2008), 300–308.
9. Gerson, A.C., Butler, R., Moxey-Mims, M., et al. Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev 12:3 (2006), 208–215.
10. Haavisto, A., Korkman, M., Holmberg, C., Jalanko, H., Qvist, E., Neuropsychological profile of children with kidney transplants. Nephrol Dial Transplant 27:6 (2012), 2594–2601.
11. Reed-Knight, B., Lee, J.L., Cousins, L.A., Mee, L.L., Intellectual and academic performance in children undergoing solid organ pretransplant evaluation. Pediatr Transplant 19:2 (2015), 229–234.
12. Nieuwlaat, R., Wilczynski, N., Navarro, T., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, 11, 2014, CD000011.
13. Fine, R.N., Becker, Y., De Geest, S., et al. Nonadherence consensus conference summary report. Am J Transplant 9:1 (2009), 35–41.
14. De Bleser, L., Matteson, M., Dobbels, F., Russell, C., De Geest, S., Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int 22:8 (2009), 780–797.
15. Bonner, S., Zimmerman, B.J., Evans, D., Irigoyen, M., Resnick, D., Mellins, R.B., An individualized intervention to improve asthma management among urban Latino and African-American families. J Asthma 39:2 (2002), 167–179.
16. Rapoff, M.A., Belmont, J., Lindsley, C., Olson, N., Morris, J., Padur, J., Prevention of nonadherence to nonsteroidal anti-inflammatory medications for newly diagnosed patients with juvenile rheumatoid arthritis. Health Psychol 21:6 (2002), 620–623.
17. Nansel, T.R., Iannotti, R.J., Simons-Morton, B.G., Plotnick, L.P., Clark, L.M., Zeitzoff, L., Long-term maintenance of treatment outcomes: diabetes personal trainer intervention for youth with type 1 diabetes. Diabetes Care 32:5 (2009), 807–809.
18. Kahana, S., Drotar, D., Frazier, T., Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 33:6 (2008), 590–611.
19. Miloh, T., Annunziato, R., Arnon, R., et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Pediatrics 124:5 (2009), e844–e850.
20. Reese, P.P., Bloom, R.D., Trofe-Clark, J., et al. Automated reminders and physician notification to promote immunosuppression adherence among kidney transplant recipients: a randomized trial. Am J Kidney Dis 69:3 (2017), 400–409.
21. Demonceau, J., Ruppar, T., Kristanto, P., et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 73:6 (2013), 545–562.
22. Mistry, N., Keepanasseril, A., Wilczynski, N.L., et al. Technology-mediated interventions for enhancing medication adherence. J Am Med Inform Assoc 22:e1 (2015), e177–e193.
23. Nevins, T.E., Nickerson, P.W., Dew, M.A., Understanding medication nonadherence after kidney transplant. J Am Soc Nephrol 28:8 (2017), 2290–2301.
24. Vrijens, B., De Geest, S., Hughes, D.A., et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73:5 (2012), 691–705.
25. Foster, B.J., Pai, A., Zhao, H., Furth, S., TAKE-IT Study Group. The TAKE-IT study: aims, design, and methods. BMC Nephrol, 15, 2014, 139.
26. Denhaerynck, K., Steiger, J., Bock, A., et al. Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 7:1 (2007), 108–116.
27. Simons, L.E., Blount, R.L., Identifying barriers to medication adherence in adolescent transplant recipients. J Pediatr Psychol 32:7 (2007), 831–844.
28. Zelikovsky, N., Schast, A.P., Eliciting accurate reports of adherence in a clinical interview: development of the Medical Adherence Measure. Pediatr Nurs 34:2 (2008), 141–146.
29. Modi, A.C., Pai, A.L., Hommel, K.A., et al. Pediatric self-management: a framework for research, practice, and policy. Pediatrics 129:2 (2012), e473–e485.
30. Pai, A.L., Gray, E., Kurivial, K., Ross, J., Schoborg, D., Goebel, J., The Allocation of Treatment Responsibility scale: a novel tool for assessing patient and caregiver management of pediatric medical treatment regimens. Pediatr Transplant 14:8 (2010), 993–999.
31. De Geest, S., Schafer-Keller, P., Denhaerynck, K., et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 20:3 (2006), 359–368.
32. Kuypers, D.R., Peeters, P.C., Sennesael, J.J., et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation 95:2 (2013), 333–340.
33. Schafer-Keller, P., Steiger, J., Bock, A., Denhaerynck, K., De Geest, S., Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 8:3 (2008), 616–626.
34. Dobbels, F., De Bleser, L., Berben, L., et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. J Heart Lung Transplant 36:5 (2017), 499–508.
35. Schwartz, G.J., Munoz, A., Schneider, M.F., et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:3 (2009), 629–637.
36. Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
37. Denhaerynck, K., Schafer-Keller, P., Young, J., Steiger, J., Bock, A., De Geest, S., Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol, 8, 2008, 5.
38. Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS. 2012. http://support.sas.com/resources/papers/proceedings12/335-2012.pdf. Accessed October 26, 2017.
39. Langkamp, D.L., Lehman, A., Lemeshow, S., Techniques for handling missing data in secondary analyses of large surveys. Acad Pediatr 10:3 (2010), 205–210.
40. Seaman, S.R., White, I.R., Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 22:3 (2013), 278–295.
41. Gross, R., Bellamy, S.L., Chapman, J., et al. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med 173:4 (2013), 300–306.
42. Quittner, A.L., Modi, A.C., Roux, A.L., Psychosocial challenges and clinical interventions for children with cystic fibrosis: a developmental approach. Brown, R., (eds.) Handbook of Pediatric Psychology in School Settings, 2003, Lawrence Erlbaum Associates, Mahwah, New Jersey, 333–361.
43. Quittner, A.L., Modi, A.C., Lemanek, K.L., Ievers-Landis, C.E., Rapoff, M.A., Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol 33:9 (2008), 916–936 discussion 937-938.
44. Shi, L., Liu, J., Fonseca, V., Walker, P., Kalsekar, A., Pawaskar, M., Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes, 8, 2010, 99.
45. Stirratt, M.J., Dunbar-Jacob, J., Crane, H.M., et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med 5:4 (2015), 470–482.
46. Sapir-Pichhadze, R., Wang, Y., Famure, O., Li, Y., Kim, S.J., Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure. Kidney Int 85:6 (2014), 1404–1411.
47. Ginevri, F., Nocera, A., Comoli, P., et al. Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. Am J Transplant 12:12 (2012), 3355–3362.
48. Kim, J.J., Balasubramanian, R., Michaelides, G., et al. The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients. Am J Transplant 14:10 (2014), 2350–2358.
49. Wiebe, C., Gibson, I.W., Blydt-Hansen, T.D., et al. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. Am J Transplant 15:11 (2015), 2921–2930.
50. Wiebe, C., Nevins, T.E., Robiner, W.N., Thomas, W., Matas, A.J., Nickerson, P.W., The synergistic effect of class II HLA epitope-mismatch and nonadherence on acute rejection and graft survival. Am J Transplant 15:8 (2015), 2197–2202.
51. Axelrod, D.A., Schnitzler, M.A., Xiao, H., et al. The changing financial landscape of renal transplant practice: a national cohort analysis. Am J Transplant 17:2 (2017), 377–389.